Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProVen VCT is a Venture Capital Trust managed by Beringea, specializing in investments in high-growth, unquoted small and medium-sized enterprises (SMEs) in the United Kingdom. The company provides a tax-efficient vehicle for private investors to gain exposure to a diversified portfolio of innovative businesses across various sectors. While sector-agnostic, ProVen VCT has a strong track record of investing in healthcare, digital health, and life sciences, supporting companies from early-stage growth to scaling operations. The trust is listed on the London Stock Exchange and focuses on generating long-term capital appreciation and sustainable dividend yield for its shareholders. Its investment strategy emphasizes companies with proven business models and strong management teams looking for expansion capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProVen VCT.